Keyphrases
Mortality Prediction
100%
Endostatin
100%
Pulmonary Arterial Hypertension
100%
Angiostatic
100%
Hypertension Risk
23%
European Respiratory Society
15%
Mortality Risk
15%
Risk Prediction Model
15%
Disease Severity
7%
Hazard Ratio
7%
Clinical Variables
7%
Cox Proportional Hazards Model
7%
Risk Prediction
7%
C-statistic
7%
Clinical Data
7%
Multivariable Regression
7%
Survival Time
7%
Endothelial Viability
7%
Pulmonary Microvascular Endothelial Cells (PMVECs)
7%
Survival Model
7%
Disease-specific Mortality
7%
Observational Cohort Study
7%
Endothelial Cell Migration
7%
Survival Prediction
7%
Akaike Information Criterion
7%
Bayesian Information Criterion
7%
Pulmonary Vascular Resistance
7%
Right Atrial Pressure
7%
Disease Biology
7%
Endothelial Cell Proliferation
7%
Risk Assessment
7%
Likelihood Ratio Test
7%
Independent Predictors of Mortality
7%
Non-invasive Biomarkers
7%
Low-risk Criteria
7%
Risk Prediction Tool
7%
Null Model
7%
6-minute Walk Distance (6MWD)
7%
Mean Pulmonary Artery Pressure (mPAP)
7%
Criteria-based
7%
Risk Assessment Strategy
7%
Prognostic Performance
7%
Test Information
7%
Fundamental Causes of Disease
7%
Severity Risk
7%
Prediction Strategy
7%
Medicine and Dentistry
Pulmonary Hypertension
100%
Endostatin
100%
Disease
7%
Hemodynamic
7%
Disease Severity
7%
Proportional Hazards Model
7%
In Vitro
7%
Cell Proliferation
7%
Hazard Ratio
7%
Lung Artery Pressure
7%
Cell Survival
7%
Cell Migration
7%
Survival Time
7%
Pulmonary Artery
7%
Enzyme Linked Immunosorbent Assay
7%
Cohort Study
7%
Endothelial Cell
7%
Lung Vascular Resistance
7%
Akaike Information Criterion
7%
Heart Right Atrium Pressure
7%
Bayesian Information Criterion
7%